1.78
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.75 -0.03 -1.69%
loading

Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten

pulisher
05:00 AM

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - StockTitan

05:00 AM
pulisher
Oct 31, 2024

Bunion Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Heron Therapeutics, Lotus Clinical Research, Cali Pharma, Grünenthal GmbH, Pacira Pharma, Inc, Mallinckrodt - The Globe and Mail

Oct 31, 2024
pulisher
Oct 29, 2024

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - Longview News-Journal

Oct 29, 2024
pulisher
Oct 26, 2024

SG Americas Securities LLC Cuts Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 26, 2024
pulisher
Oct 21, 2024

Antinauseants Market Insights, Forecast to 2031Heron - openPR

Oct 21, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 6,328 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 20, 2024
pulisher
Oct 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Heron Therapeutics Inc (HRTX) deserves deeper analysis - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Investor’s Toolkit: Key Ratios for Assessing Heron Therapeutics Inc (HRTX)’s Performance - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Congress Park Capital LLC - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - The Malaysian Reserve

Oct 10, 2024
pulisher
Oct 09, 2024

Its Stock Has Paid Off Big Time For Heron Therapeutics Inc - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

AQR Capital Management LLC Raises Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Heron Therapeutics Inc Inc. (HRTX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

Can you now get a good deal on Heron Therapeutics Inc’s shares? - US Post News

Oct 08, 2024
pulisher
Oct 06, 2024

Squarepoint Ops LLC Purchases 286,160 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 06, 2024
pulisher
Oct 03, 2024

Buying Buzz: Heron Therapeutics Inc [HRTX] EVP, Chief Development Officer Forbes William P purchases 25,000 shares of the company – Knox Daily - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

HRTX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

When Can We Expect A Profit From Heron Therapeutics, Inc. (NASDAQ:HRTX)? - Simply Wall St

Oct 03, 2024
pulisher
Oct 02, 2024

Get in on Heron Therapeutics Inc’s (HRTX) buy-in window today! - SETE News

Oct 02, 2024
pulisher
Oct 02, 2024

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - Yahoo Finance

Oct 02, 2024
pulisher
Oct 01, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by Marshall Wace LLP - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Heron Therapeutics Inc’s results are impressive - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Marshall Wace LLP Boosts Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Market Momentum Report: Heron Therapeutics Inc (HRTX)’s Negative Close at 1.99 - The Dwinnex

Sep 30, 2024
pulisher
Sep 29, 2024

Clearline Capital LP Sells 1,280,938 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Heron gains on FDA nod for new Zynrelef application - MSN

Sep 26, 2024
pulisher
Sep 26, 2024

Renaissance Technologies LLC Reduces Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Heron Therapeutics Inc [NASDAQ: HRTX] Sees Decrease in Stock Value - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Renaissance Technologies LLC Lowers Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Needham & Company LLC Reaffirms "Buy" Rating for Heron Therapeutics (NASDAQ:HRTX) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Adversity is less terrifying than hope: Heron Therapeutics Inc (HRTX) - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Heron stock gains on FDA nod for Zynrelef method (NASDAQ:HRTX) - Seeking Alpha

Sep 25, 2024
pulisher
Sep 25, 2024

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PR Newswire

Sep 25, 2024
pulisher
Sep 25, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Rhumbline Advisers - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Heron Therapeutics Inc (HRTX) stock on the rise: An overview - US Post News

Sep 24, 2024
pulisher
Sep 21, 2024

Wealth Alliance Has $112,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Acadian Asset Management LLC Makes New Investment in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

E Fund Management Co. Ltd. Acquires New Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Orchard Capital Management LLC - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Bank of New York Mellon Corp Purchases 113,655 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Pekin Hardy Strauss Inc. Has $88,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Richmond Brothers Inc. - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Monitoring Heron Therapeutics Inc (HRTX) after recent insider movements - Knox Daily

Sep 18, 2024
pulisher
Sep 17, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Principal Financial Group Inc. - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Heron Therapeutics Inc (HRTX) stock: A year of ups and downs - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Chemotherapy Induced Nausea and Vomiting Treatment Market is Set to Reach US$ 12,688.0 Million by 2034 | Fact.MR - GlobeNewswire Inc.

Sep 17, 2024
pulisher
Sep 16, 2024

Holdings of Heron Therapeutics Inc (HRTX) are aligned with the stars - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Market Highlights: Heron Therapeutics Inc (HRTX) Ends on a High Note at 1.87 - The Dwinnex

Sep 16, 2024
pulisher
Sep 14, 2024

Headlands Technologies LLC Acquires 79,609 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Los Angeles Capital Management LLC - Defense World

Sep 13, 2024
pulisher
Sep 11, 2024

The time has not yet come to remove your chips from the table: Heron Therapeutics Inc (HRTX) - SETE News

Sep 11, 2024
pulisher
Sep 11, 2024

Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors - Seeking Alpha

Sep 11, 2024
pulisher
Sep 11, 2024

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 10, 2024

How should investors view Heron Therapeutics Inc (HRTX)? - US Post News

Sep 10, 2024
pulisher
Sep 10, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Monaco Asset Management SAM - MarketBeat

Sep 10, 2024
pulisher
Sep 09, 2024

Market Recap: Heron Therapeutics Inc (HRTX)’s financial ratios: A comprehensive overview - The Dwinnex

Sep 09, 2024
pulisher
Sep 07, 2024

Heron Therapeutics announces second-quarter financial results - Healio

Sep 07, 2024
$19.96
price up icon 5.11%
$75.75
price down icon 0.50%
$376.80
price up icon 0.74%
$53.54
price down icon 2.00%
$207.25
price up icon 1.49%
$108.97
price down icon 2.25%
Kapitalisierung:     |  Volumen (24h):